IBDEI0PA ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25445,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25445,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,25445,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,25446,0)
 ;;=A81.09^^97^1200^7
 ;;^UTILITY(U,$J,358.3,25446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25446,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,25446,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,25446,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,25447,0)
 ;;=A81.2^^97^1200^72
 ;;^UTILITY(U,$J,358.3,25447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25447,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,25447,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,25447,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,25448,0)
 ;;=F01.50^^97^1200^46
 ;;^UTILITY(U,$J,358.3,25448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25448,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25448,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,25448,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,25449,0)
 ;;=F01.51^^97^1200^47
 ;;^UTILITY(U,$J,358.3,25449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25449,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25449,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,25449,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,25450,0)
 ;;=F02.80^^97^1200^34
 ;;^UTILITY(U,$J,358.3,25450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25450,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25450,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25450,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25451,0)
 ;;=F02.81^^97^1200^35
 ;;^UTILITY(U,$J,358.3,25451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25451,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25451,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,25451,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,25452,0)
 ;;=G30.9^^97^1200^4
 ;;^UTILITY(U,$J,358.3,25452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25452,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25452,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,25452,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,25453,0)
 ;;=G31.01^^97^1200^70
 ;;^UTILITY(U,$J,358.3,25453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25453,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,25453,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,25453,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,25454,0)
 ;;=G94.^^97^1200^6
 ;;^UTILITY(U,$J,358.3,25454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25454,1,3,0)
 ;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,25454,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,25454,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,25455,0)
 ;;=G31.83^^97^1200^18
 ;;^UTILITY(U,$J,358.3,25455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25455,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,25455,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,25455,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,25456,0)
 ;;=G31.89^^97^1200^11
 ;;^UTILITY(U,$J,358.3,25456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25456,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System NEC
 ;;^UTILITY(U,$J,358.3,25456,1,4,0)
 ;;=4^G31.89
 ;;^UTILITY(U,$J,358.3,25456,2)
 ;;=^5003814
 ;;^UTILITY(U,$J,358.3,25457,0)
 ;;=G31.9^^97^1200^12
 ;;^UTILITY(U,$J,358.3,25457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25457,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,25457,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,25457,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,25458,0)
 ;;=G23.8^^97^1200^10
 ;;^UTILITY(U,$J,358.3,25458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25458,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,25458,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,25458,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,25459,0)
 ;;=G30.0^^97^1200^2
 ;;^UTILITY(U,$J,358.3,25459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25459,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,25459,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,25459,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,25460,0)
 ;;=G30.1^^97^1200^3
 ;;^UTILITY(U,$J,358.3,25460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25460,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,25460,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,25460,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,25461,0)
 ;;=B20.^^97^1200^21
 ;;^UTILITY(U,$J,358.3,25461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25461,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,25461,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,25461,2)
 ;;=^5000555^
 ;;^UTILITY(U,$J,358.3,25462,0)
 ;;=G10.^^97^1200^22
 ;;^UTILITY(U,$J,358.3,25462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25462,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,25462,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,25462,2)
 ;;=^5003751^
 ;;^UTILITY(U,$J,358.3,25463,0)
 ;;=G30.8^^97^1200^1
 ;;^UTILITY(U,$J,358.3,25463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25463,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,25463,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,25463,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,25464,0)
 ;;=A81.89^^97^1200^5
 ;;^UTILITY(U,$J,358.3,25464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25464,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,25464,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,25464,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,25465,0)
 ;;=G20.^^97^1200^69
 ;;^UTILITY(U,$J,358.3,25465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25465,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,25465,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,25465,2)
 ;;=^5003770^
 ;;^UTILITY(U,$J,358.3,25466,0)
 ;;=G23.1^^97^1200^73
 ;;^UTILITY(U,$J,358.3,25466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25466,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,25466,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,25466,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,25467,0)
 ;;=F03.91^^97^1200^17
 ;;^UTILITY(U,$J,358.3,25467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25467,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25467,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,25467,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,25468,0)
 ;;=F03.90^^97^1200^19
 ;;^UTILITY(U,$J,358.3,25468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25468,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25468,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,25468,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,25469,0)
 ;;=F02.81^^97^1200^40
 ;;^UTILITY(U,$J,358.3,25469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25469,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25469,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,25469,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,25470,0)
 ;;=F02.80^^97^1200^41
 ;;^UTILITY(U,$J,358.3,25470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25470,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25470,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25470,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25471,0)
 ;;=G31.84^^97^1200^56
 ;;^UTILITY(U,$J,358.3,25471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25471,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,25471,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,25471,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,25472,0)
 ;;=F02.81^^97^1200^24
 ;;^UTILITY(U,$J,358.3,25472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25472,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/ Behav Disturb
